As research into the development of an HIV cure gains prominence, assessing the perspectives of stakeholders becomes imperative. It empowers stakeholders to determine priorities and influence research processes. We conducted a systematic review of the empirical literature on stakeholder perspectives. PubMed, Embase, Web of Science, and Scopus were searched for empirical, peer-reviewed articles, published before September 2022. Our analysis of 78 papers showed that stakeholders could be divided into three categories: people with HIV, key populations, and professionals. Following thematic synthesis, two main themes were distinguished: stakeholders' perspectives on HIV cure research and stakeholders' perspectives on HIV cure. Research on persp...
In the United States, young adults have the highest rates of new HIV infections, and are less likely...
BACKGROUND: Analytical treatment interruptions (ATI) are commonly used clinical endpoints to assess ...
Despite huge advances in the fight against HIV concerning diagnosis, clinical efficacy of antiretrov...
As research into the development of an HIV cure gains prominence, assessing the perspectives of stak...
Clinical and basic science advances have raised considerable hope for achieving an HIV cure by accel...
Introduction: Involving affected communities and people living with HIV (PLHIV) in HIV cure-focused ...
Background: Research on stakeholder perspectives of HIV cure research has involved people with HIV (...
IntroductionStakeholder engagement is an essential component of HIV clinical trials. We define stake...
IntroductionThe question of what motivates people to participate in research is particularly salient...
OBJECTIVES Involvement of people living with HIV (PLHIV) in the design of HIV cure studies is imp...
Participation in HIV cure-related clinical trials that involve antiretroviral treatment (ART) interr...
Consent processes for clinical trials involving HIV prevention research have generated considerable ...
Participation in HIV cure-related clinical trials that involve antiretroviral treatment (ART) interr...
BackgroundThe pursuit of a cure for HIV is a high priority for researchers, funding agencies, govern...
International audienceContextDespite huge advances in the fight against HIV concerning diagnosis, cl...
In the United States, young adults have the highest rates of new HIV infections, and are less likely...
BACKGROUND: Analytical treatment interruptions (ATI) are commonly used clinical endpoints to assess ...
Despite huge advances in the fight against HIV concerning diagnosis, clinical efficacy of antiretrov...
As research into the development of an HIV cure gains prominence, assessing the perspectives of stak...
Clinical and basic science advances have raised considerable hope for achieving an HIV cure by accel...
Introduction: Involving affected communities and people living with HIV (PLHIV) in HIV cure-focused ...
Background: Research on stakeholder perspectives of HIV cure research has involved people with HIV (...
IntroductionStakeholder engagement is an essential component of HIV clinical trials. We define stake...
IntroductionThe question of what motivates people to participate in research is particularly salient...
OBJECTIVES Involvement of people living with HIV (PLHIV) in the design of HIV cure studies is imp...
Participation in HIV cure-related clinical trials that involve antiretroviral treatment (ART) interr...
Consent processes for clinical trials involving HIV prevention research have generated considerable ...
Participation in HIV cure-related clinical trials that involve antiretroviral treatment (ART) interr...
BackgroundThe pursuit of a cure for HIV is a high priority for researchers, funding agencies, govern...
International audienceContextDespite huge advances in the fight against HIV concerning diagnosis, cl...
In the United States, young adults have the highest rates of new HIV infections, and are less likely...
BACKGROUND: Analytical treatment interruptions (ATI) are commonly used clinical endpoints to assess ...
Despite huge advances in the fight against HIV concerning diagnosis, clinical efficacy of antiretrov...